✦ LIBER ✦

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

✍ Scribed by Shepherd, Frances A.; Rodrigues Pereira, José; Ciuleanu, Tudor; Tan, Eng Huat; Hirsh, Vera; Thongprasert, Sumitra; Campos, Daniel; Maoleekoonpiroj, Savitree; Smylie, Michael; Martins, Renato; van Kooten, Maximiliano; Dediu, Mircea; Findlay, Brian; Tu, Dongsheng; Johnston, Dianne; Bezjak, Andrea; Clark, Gary; Santabárbara, Pedro; Seymour, Lesley

Book ID: 120548297
Publisher: Massachusetts Medical Society
Year: 2005
Tongue: English
Weight: 269 KB
Volume: 353
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa050753

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical efficacy of erlotinib in patien

Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer

✍ Songwen ZHOU; Shengxiang REN; Lianghua YAN; Ling ZHANG; Liang TANG; Jie ZHANG; C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB

Erlotinib in a previously treated advanc

Erlotinib in a previously treated advanced non-small cell lung cancer elderly patient: a clinical case

✍ C. Gridelli; A. Rossi; P. Maione; C. Ferrara; F. Del Gaizo; D. Nicolella; C. Gue 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 91 KB

Randomized Phase II Study of Erlotinib P

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non-Small-Cell Lung Cancer

✍ Sequist, L. V.; von Pawel, J.; Garmey, E. G.; Akerley, W. L.; Brugger, W.; Ferra 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 205 KB

Phase III Trial of Vandetanib Compared W

Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

✍ Natale, R. B.; Thongprasert, S.; Greco, F. A.; Thomas, M.; Tsai, C.-M.; Sunpawer 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 298 KB

PCN58 A COST UTILITY ANALYSIS OF ERLOTIN

PCN58 A COST UTILITY ANALYSIS OF ERLOTINIB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)

✍ PA Bradbury; R Jang; P Isogai; R Ng; N Mittmann; W Evans; FA Shepherd; NB Leighl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

9174 Phase II study of everolimus plus e

9174 Phase II study of everolimus plus erlotinib in previously treated patients with advanced non-small cell lung cancer (NSCLC)

✍ Soria, J.C.; Bennouna, J.; Leighl, N.; Khuri, F.; Traynor, A.M.; Johnson, B.; Ka 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB